戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lus optimized background therapy (randomized cohort).
2 thin a 20-year follow-up (ECRHS and SAPALDIA cohorts).
3 efine the natural history of NSE in an Irish cohort.
4 ze the prognostic factors of EE in the GAMES cohort.
5 nd validated these results in an independent cohort.
6  in the 40-Gy cohort compared with the 50-Gy cohort.
7 0.798 (95% CI 0.789-0.818) in the validation cohort.
8 which were weakly supported in a replication cohort.
9 19 cells per muL (202) in the non-randomised cohort.
10      Findings were confirmed in a validation cohort.
11  to a subject at the 10th percentile in this cohort.
12 escents was confirmed in a larger validation cohort.
13 o type 1 diabetes in a prospective high-risk cohort.
14 red after 11 days of treatment in the 300 mg cohort.
15 307 DNA methylations in the TCGA lung cancer cohort.
16 dy and deemed eligible for inclusion in this cohort.
17 trated for the first time in a large patient cohort.
18 akophilin 2 (PKP2) mutations as a comparison cohort.
19 direction of association as in the discovery cohort.
20 dystrophy disorders in a large clinical care cohort.
21 lit into training (n = 97) and test (n = 49) cohorts.
22 ounted for 5% of infant MB(SHH) cases in our cohorts.
23 e patterns change over time and across birth cohorts.
24 iously quantified in three independent human cohorts.
25 9 and HDAC4 that were consistent across both cohorts.
26 s muscle volume that can be applied to large cohorts.
27 % CI, 0.92-0.95) were used as the validation cohorts.
28 levels in several carefully phenotyped human cohorts.
29 and patients on OST in comparison to control cohorts.
30 atitis, but not for BPH, were observed among cohorts.
31 upported by clinical data from ICB treatment cohorts.
32 s evaluated in four clinic-based prospective cohorts.
33                                              Cohort 1 (n = 24,475) was examined during 1971 to 1991 a
34 est level of specificity (100% in validation cohort 1 and 87.8% in validation cohort 2), with sensiti
35  on Day 10 after daily doses of either 4 mg (Cohorts 1 and 2), or 1 mg (Cohort 3).
36 9 participants of the Northern Finland Birth Cohort 1966 who had reported LBP over the previous 12 mo
37                                              Cohort 2 was used to apply those scores for analysis of
38  validation cohort 1 and 87.8% in validation cohort 2), with sensitivity values of 37.3% and 30.0%, r
39                                       In our cohort, 296 (2.1%) household contacts had coprevalent TB
40 s of either 4 mg (Cohorts 1 and 2), or 1 mg (Cohort 3).
41  single ascending dose study consisting of 3 cohorts (40, 80, 120 mg MMV390048).
42  change rates from the multisite Track-On HD cohort (74 pre-HD, 79 control participants).
43                             Within our study cohort, 8,680 (83%) underwent SG and 1,771 (17%) underwe
44                        For the early-treated cohort (83 HIV-1 adult patients treated within 3 months
45  with manifest keratoconus in both eyes (KCE cohort), 9 subjects with very asymmetric ectasia (VAE co
46 ecificity 65%) and 0.740 in the contemporary cohort (95% confidence interval: 0.723-0.758; sensitivit
47 r prevalent diabetes of 0.766 in the primary cohort (95% confidence interval: 0.750-0.782; sensitivit
48 etabolic activity in tumors, is also in this cohort a measure of tumor volume.
49   Compared with the propensity score-matched cohort, a significantly longer OS was observed with HER2
50                               For the entire cohort, a wider margin width was not associated with a r
51 m ACCORD (N = 585, P = 0.02) and in external cohorts (ACCORD-BP, ORIGIN, and TRIUMPH, total N = 3059,
52 rve analysis was performed in the derivation cohort achieved an AUC of 0.824 (95% CI 0.814-0.851) and
53 virologic suppression are lower in the total cohort among those with PDR 65% (73/112) compared to tho
54 205 cells per muL (SD 191) in the randomised cohort and 119 cells per muL (202) in the non-randomised
55  CI 7.2-not estimable [NE]) in the EZH2(mut) cohort and 13.0 months (5.6-NE) in the EZH2(WT) cohort;
56      12 (4%) of 272 people in the randomised cohort and 17 (17%) of 99 in the non-randomised cohort d
57 I 53-82; 31 of 45 patients) in the EZH2(mut) cohort and 35% (23-49; 19 of 54 patients) in the EZH2(WT
58 patients with COVID-19 in the intensive care cohort and 84.7% of those in the hospitalized nonintensi
59 itivity analyses were conducted using an ICU cohort and Acute Physiology and Chronic Health Evaluatio
60  We performed whole exome sequencing on this cohort and applied 2 hypotheses to our variant filtering
61    Campylobacter infection is common in this cohort and associated with changes in microbial communit
62  as his/her own control (as we see with case-cohort and case-crossover studies, for example).
63 scriptome analysis on a large ovarian tumour cohort and develop a machine learning approach to molecu
64 n the Childhood Cancer Survivor Study (CCSS) cohort and validated in the St Jude Lifetime Cohort (SJL
65 om 185 young women (average age 21.2) in two cohorts and tested the effects of OC on plasma levels of
66 rmance was evaluated internally (in the CCSS cohort) and externally (in the SJLIFE cohort) using the
67 reactivity was evident in the sera of the MS cohort, and the antibodies bound a heterogeneous set of
68  parent did so in the Framingham Heart Study cohorts, and estimated the incidence rates and hazard ra
69 diatric HIV/AIDS Cohort Study (PHACS) AMP Up cohort approaching or having completed transition from p
70 -term outcomes of large NAFLD-associated HCC cohorts are lacking.
71            The size and diversity of the MVP cohort, as well as the availability of extensive VA elec
72 imulations faithfully reproduce the clinical cohort at three levels long-term response (OS), the init
73 e 6-10 years of a multicentre European birth cohort based was undertaken using an online parental que
74                                Thus, using a cohort-based whole-genome-sequencing approach in the dia
75 ilies enrolled in the Wisconsin Infant Study Cohort birth cohort study.
76 on, the heritability was higher in the older cohorts born in 1900-1949 (a(2) = 0.44; 0.41-0.46) than
77 9 (a(2) = 0.44; 0.41-0.46) than in the later cohorts born in 1950-1989 (a(2) = 0.38; 0.36-0.40), with
78 related death caused by grade 4 dyspnoea (in cohort C).
79 d a second variant in FAF1 in the validation cohort (c.254G>C; p.Arg85Pro).
80 no difference or better outcome in the 40-Gy cohort compared with the 50-Gy cohort.
81                                The pediatric cohort comprised 452 individuals from 411 families (66 g
82                                 The referral cohort consisted of a total of 22 876 referrals for aort
83 uenza cases (n = 50), and (ii) an immunology cohort, consisting of paired sera collected after PCR-co
84 s in Auckland, New Zealand: (i) a serosurvey cohort, consisting of pre- and post-influenza season ser
85                   In a breast cancer patient cohort coupled with in silico analysis of publicly avail
86 ears posttransplant; and the Cross sectional Cohort (CSC, n=446): patients developing new-onset renal
87                              Moreover, human cohort data have revealed differential DNA methylation s
88                          We also present our cohort data in light of clinical features reported for e
89  preceding AION were included in the pcsAION cohort defined in 2 ways: AION within 2 months and AION
90 ate logistic regression of the retrospective cohort demonstrated predictors of infection.
91 nd interrogation of four independent patient cohorts detected BCL2L14-ETV6 in 4.4 to 12.2% of TNBC tu
92 ort and 17 (17%) of 99 in the non-randomised cohort died; the median baseline CD4 count for participa
93                                         Both cohorts (discovery: n = 182; replication: n = 326) inclu
94 s should focus on the use of un-bias patient cohorts, double-blinded index test and detection assays
95 r cardiovascular mortality in the 2 external cohorts (eg, HRs of IDH by the 2017 ACC/AHA definition w
96 ts with rhinitis from 2 multicenter European cohorts (Epidemiological Study on the Genetics and Envir
97                 We screened an Asian-Pacific cohort for CANVAS and identified a novel RFC1 repeat exp
98 ternally validated, and externally tested on cohorts from two academic institutions.Measurements and
99  After adjustment, current DMPA users (7% of cohort) had blood lead concentrations that were 18% high
100                   Four patients, two in each cohort, had complete responses.
101 Bage) and current smoking (PAF 4.9% for both cohorts) having the strongest association.
102 ited, along with 61 age- and sex-matched (by cohort) healthy controls.
103 ith in silico analysis of publicly available cohorts, high expression of USP11 was significantly asso
104 lected from participants in an observational cohort in Australia.
105                     We focus here on a study cohort in Delhi on one of the most prevalent HLA-B allel
106 Generation R Study, a population-based birth cohort in Rotterdam, Netherlands (enrollment 2002-2006).
107 to HA and NA in two naturally infected human cohorts in Auckland, New Zealand: (i) a serosurvey cohor
108                                    The study cohort included 1,135,441 outpatient surgeries performed
109                                    The study cohort included 157 patients; 24 (15%), 124 (79%), and 9
110                                   The second cohort included 28 Parkinson's disease and 43 control sa
111                               The 76-patient cohort included 55 paroxysmal and 21 persistent atrial f
112                                    The first cohort included eyes with mild glaucoma (abnormal glauco
113                                          Our cohort included patients classified in BCLC stage 0 (9.4
114                                          The cohort included racially/ethnically diverse pregnant wom
115           Adverse prognostic features of the cohort included short median PSA doubling time (2.3 mo)
116 obtaining detailed histories, we divided the cohort into three groups: participants without a history
117 Aberrant biomarker expression stratified the cohorts into 3 distinct prognostic groups.
118               cfDNA hydroxymethylome in PDAC cohort is differentially enriched for genes that are com
119  16S rRNA sequencing; an independent Western cohort is used for external validation.
120 FTD, but the creation of large multinational cohorts is facilitating better powered studies and will
121 ate in 1,976 subjects of a German population cohort (KORA) that specific microbiota members show 24-h
122   The different results obtained for the two cohorts may reflect a delayed effect of season of concep
123 5% (23-49; 19 of 54 patients) in the EZH2(WT cohort.) Median duration of response was 10.9 months (95
124 ort and 13.0 months (5.6-NE) in the EZH2(WT) cohort; median progression-free survival was 13.8 months
125                                       Markov cohort models were used to estimate the impact on IHD bu
126                           In the replication cohorts, multiple SNPs in strong linkage disequilibrium
127 ort (n = 64) in comparison with a non-cancer cohort (n = 243).
128                                   The PrOMIS cohort (N = 3308) was recruited from prenatal care clini
129                              With a training cohort (n = 40) and a blinded validation cohort (n = 90)
130 ges in circulating cell free DNA from a PDAC cohort (n = 64) in comparison with a non-cancer cohort (
131                      In the norm-albuminuria cohort (n = 75) baseline UPPod:CR was associated with de
132 ing cohort (n = 40) and a blinded validation cohort (n = 90) acquired from CDC, the Lyme Immunochip i
133                                A prospective cohort (n=116) with CysC and sCr concurrently measured a
134 d at serial time points, and a retrospective cohort (n=91) with chest computed tomography performed w
135 pe of CEP290 mutations in the largest German cohort observed by a single clinical site.
136 tegy to diagnose cirrhosis in a hypothetical cohort of 1,000 asymptomatic patients.
137 ion of behavioural deficits in a prospective cohort of 132 first-time stroke patients studied at 2 we
138 imaging parameters) up to 6 years later in a cohort of 143 patients.
139                               A longitudinal cohort of 1908 children ages 1-9 years in Tanzania from
140                                   In a large cohort of 302 volunteers, early morning vaccination resu
141 man immunodeficiency virus (HIV)-negative UK cohort of 333 tuberculosis contacts.
142                                      Using a cohort of 404 patients comprising different subtypes of
143 ogic assessment in an independent validation cohort of 56 additional cases.
144   We aimed to address these unknowns using a cohort of 57 participants diagnosed with Alzheimer's dis
145  Asthma in Childhood 2010(2010) mother-child cohort of 700 children growing up in areas with differen
146  the sera of 51 adult ICL patients (out of a cohort of 72).
147 in the GULF-COAST, a prospective multicenter cohort of acute coronary syndrome (ACS), in relation to
148 ledge, this study is the longest prospective cohort of an H pylori eradication trial in a Hispanic po
149 se Risk Development in Young Adults study, a cohort of black and white young adults, we evaluated the
150 ich are being further evaluated with a large cohort of blinded samples from the CDC and Columbia Univ
151 sk Longitudinal Twin Study, a representative cohort of British twins (n = 2,232) followed across the
152 investigation of the largest cross-sectional cohort of CHIKV-deaths to date reveals that CHIKV-ECSA s
153                      We could show that in a cohort of children with a first unprovoked seizure, ripp
154 231 plasma and 97 fecal samples from a large cohort of children with ASD and typically developing con
155 a follow-up period of at least 10 years in a cohort of children.
156 roducibility of these ICNs in an independent cohort of HCs, and recapitulated their functional releva
157 age results were confirmed in an independent cohort of healthy controls.
158 e longitudinal humoral response to KSHV in a cohort of HIV-infected Zambian mothers without KS and id
159 ors associated with survival time in a large cohort of HIV/HTLV-1-coinfected and HIV-monoinfected ind
160 ere confirmed in the urine of an independent cohort of IgAN patients compared with non-IgAN patients
161 te of documented SARS-CoV-2 reinfection in a cohort of laboratory-confirmed cases in Qatar.
162 AVR valve durability on life expectancy in a cohort of low-risk patients similar to those in recent t
163 arker generalized to a drug-free independent cohort of melancholic MDD, and did not generalize to oth
164 ls infected with COVID-19, identified from a cohort of nearly 5,300 participants, and found that 26 o
165 ifidus and semispinalis cervicis) in a small cohort of participants with chronic whiplash associated
166 ficits remains to be determined with a large cohort of participants.
167 ilures) were identified from a single-centre cohort of patients admitted with refractory status epile
168 st hoc analysis of a prospectively collected cohort of patients from 35 Spanish centers from 2008 to
169 our immune microenvironment in a prospective cohort of patients who had nephrectomy for localised RCC
170                      In this large pediatric cohort of patients with BAV, valve morphology, AS, and A
171 still providing high-quality care to a large cohort of patients with heart failure, heart transplanta
172 has not yet been validated in a well-defined cohort of patients with PG.
173 ibution of NWU was analyzed in a consecutive cohort of patients with wake-up stroke.
174 irth and severe pre-eclampsia in the PreCARE cohort of pregnant women in Paris (n = 9,579).
175                              A retrospective cohort of preoperative patients within the national heal
176 bundance with a large, well-curated clinical cohort of PTEN-variant carriers.
177 mission linkages and associated factors in a cohort of PWID receiving opioid agonist therapy (OAT).
178         rs-fMRI sessions were conducted on a cohort of rabbits before and after trace eyeblink condit
179 o immunologic features were observed in this cohort of subjects with or without ICS-naive mild asthma
180 abundances in longitudinal data from the IBD cohort of the integrative human microbiome (iHMP-IBD) pr
181 ependently associated with mortality in this cohort of venoarterial extracorporeal membrane oxygenati
182 population distribution in order to create a cohort of virtual patients with some specific characteri
183 Women's Breast Cancer Study is a prospective cohort of women diagnosed with breast cancer at age <= 4
184 h risk of AAA in a large, ethnically diverse cohort of women.
185 Neuroscience in Psychiatry Network (NSPN), a cohort of young people (aged 18-29 years) in the United
186 ociated with CT/NG prevalence in a high-risk cohort of Zambian female sex workers and single mothers
187                                      Similar cohorts of infants showed an elevated risk of persistent
188                                          Two cohorts of kidney transplant recipients enrolled in the
189  complication, but studies focusing on large cohorts of patients transplanted for primary immunodefic
190 ent to open in both propensity-score matched cohorts of patients undergoing transthoracic or transhia
191 ors retrospectively analyzed two independent cohorts of patients who received left prefrontal transcr
192 record data were analyzed from retrospective cohorts of pregnant women hospitalized with ARFI who had
193 nd proportions between foveal and peripheral cohorts of shared types.
194 8 patients were enrolled on the study (49 in cohort one, six in cohort two, and 13 in cohort three).
195 East, and Asia were assigned to one of three cohorts: patients with FGFR2 fusions or rearrangements,
196 DeKAF) study were evaluated: The Prospective Cohort (PC, n=581): Patients undergoing first for cause
197                          In the ischemic FFR cohort, PCI was associated with a significantly lower ra
198 at the diagnostic accuracy of CT-FFR in this cohort potentially enables its use in clinical practice
199 e processing approach in addition to partial cohort preprocessing with a LASSO-based model, we were a
200                    These data from a limited cohort provide a critical first step in understanding th
201 rolina Center for AIDS Research HIV Clinical Cohort receiving care during 1996-2016, we estimated ann
202  each matched to 3 controls on age, sex, and cohort recruitment date.
203 1.53, 1.66, and 1.74 for the 1-, 2-, and 3-h cohorts, respectively, and a mean intrinsic fluorescence
204 mization of HPTs was associated with greater cohort retention but had little impact on incidence or t
205 lies, proband-parent trios, and case-control cohorts revealed defects in cardiomyopathy-associated ge
206 ology/American Heart Association 2013 pooled cohort risk equation.
207                                  The primary cohort's ORR(W15) was 41% (95% CI, 26% to 58%), includin
208                                  In the same cohort, sensitivity and negative predictive value of dep
209 ated this association in a prospective birth cohort setting.
210                         Patients in the 2020 cohort showed worse median VA at presentation (1.00 loga
211                           In the prospective cohort, similar intraburst theta spectral features were
212 cohort and validated in the St Jude Lifetime Cohort (SJLIFE) Study.
213 ve and automated approach will enable future cohort studies to understand the microvasculature's role
214 d, with our current knowledge based on a few cohort studies whose findings are inconsistent.
215  regimen, 48 other treatment studies, and 33 cohort studies, with a total of 179 230 participants, we
216  observed in case-control studies and not in cohort studies.
217 074 patients, 9 were case series, and 3 were cohort studies.
218 NA and 6-month follow-up in an observational cohort study (CROMIS-2).
219 reduce the intake of SSBs.The Health Workers Cohort Study (HWCS) has been approved by the Institution
220 Vs aged >=18 years in the Pediatric HIV/AIDS Cohort Study (PHACS) AMP Up cohort approaching or having
221  We sorted all participants of the Swiss HIV Cohort Study (SHCS) with at least 1 documented MTB test
222          This population-based retrospective cohort study assessed whether a validated objective and
223                                Jude Lifetime Cohort Study completed surveys assessing 10 symptom doma
224                           This retrospective cohort study examined whether bariatric surgery is assoc
225                     This large retrospective cohort study helps characterize the natural history of D
226            The JADE program is a prospective cohort study implemented in a naturalistic environment w
227                               We performed a cohort study in which the daptomycin resistance of E. fa
228  conducted a prospective long-term follow-up cohort study included 263 KTRs with grafts functioning a
229  PARTICIPANTS: Prospective, population-based cohort study of 1386 men with favorable-risk (clinical s
230 We conducted a multicountry population-based cohort study of all recorded singleton live births from
231                        This is a prospective cohort study of children, 3-18 years of age, with CAP fr
232                          In this prospective cohort study of healthy infants, stools serially collect
233              An international, retrospective cohort study of patients undergoing anterior resection w
234                 We conducted a retrospective cohort study of patients with compensated cirrhosis in t
235          We undertook a prospective, matched cohort study of patients with Staphylococcus aureus bact
236                             A retrospective, cohort study of PWID aged >=18 years admitted to a terti
237 , SETTING, AND PARTICIPANTS: A retrospective cohort study of the predictive accuracy of a previously
238 logical survey of rice farmers in Bali and a cohort study on health inequality in Amsterdam.
239      We performed a nationwide retrospective cohort study on the "Programme de Medicalisation des Sys
240 mong patients with COVID-19, a retrospective cohort study using data from Danish national administrat
241                        This population-based cohort study utilized healthcare data (2005 to 2014) fro
242                              A retrospective cohort study was conducted using US National Center for
243   An independent, prospective, observational cohort study was performed involving 127 trauma subjects
244                              A retrospective cohort study was performed of patients undergoing adrena
245                               We performed a cohort study with 21 patients suffering from ulcerative
246                        In this retrospective cohort study with a total of 857 subjects from the AD (n
247  T2D cases and 638 noncases in a nested case-cohort study within the PREDIMED Study during median fol
248 V+ and 534 HIV-) from MACS (Multicenter AIDS Cohort Study), using the ZioXT ambulatory electrocardiog
249                                      In this cohort study, prediction models of acute ovarian failure
250 UK Biobank sample and the iPSYCH Danish case-cohort study, two population-based samples from differen
251                        In this retrospective cohort study, we describe the clinical presentation and
252         In this prospective population-based cohort study, we enrolled healthy children residing in B
253 opulation-based, nationwide, and prospective cohort study.
254 th CSF leakage from a prospective nationwide cohort study.
255 d in the Wisconsin Infant Study Cohort birth cohort study.
256 lergy-risk birth cohort, the Melbourne Atopy Cohort Study.
257 nce of a common disease haplotype among this cohort suggests this novel repeat expansion configuratio
258 ared to healthy control subjects in a German cohort, supporting the concept of a role for inflammatio
259 uctive CAD more accurately in the validation cohorts than the PTP model, and markedly increased the a
260 others enrolled in a high-allergy-risk birth cohort, the Melbourne Atopy Cohort Study.
261  in cohort one, six in cohort two, and 13 in cohort three).
262 ts were randomly selected from The Malaysian Cohort (TMC) aged 35 to 70 years between 2006 and 2012.
263 ence varies from 13% in a general population cohort to as high as 78% in patients with inflammatory b
264 ic resonance studies from our Leigh syndrome cohort to provide a detailed description of central nerv
265                                Jude Lifetime Cohort treated with cyclophosphamide equivalent dose (CE
266     This open-label, single-arm, prospective cohort trial is the first phase 3 safety study to descri
267 ses of human brain samples from the NYGC ALS cohort, truncated STMN2 RNA was confined to tissues and
268 olled on the study (49 in cohort one, six in cohort two, and 13 in cohort three).
269 with neck or shoulder pain in the UK Biobank cohort, two of which were weakly supported in a replicat
270 scovery (n = 2405) and validation (n = 2313) cohorts using data from 4 recent trials (UKALL2003, COAL
271 e CCSS cohort) and externally (in the SJLIFE cohort) using the areas under the receiver operating cha
272 e ARIC (Atherosclerosis Risk In Communities) cohort, VTE risk associated with incident HF, HF subtype
273 pitalized patients, the mean (SD) age of the cohort was 60.6 (16.2) years, 103 (52.3%) were male, and
274 estimate of the 16 062 patients in the study cohort was 62.3% (95% CI 59.7-64.4).
275             One-year survival in the VA-ECMO cohort was 71%.
276                                          The cohort was assessed for subsequent future fragility frac
277                              An English BCSP cohort was derived using the electronic notifications re
278                                          The cohort was divided into training and validation data set
279  among infants with pseudostrabismus in this cohort was lower than those in previous reports and simi
280 ry case-control study within LIFECODES birth cohort was performed.
281                             The ALSPAC birth cohort was used for independent replication.
282                                       In the cohort we identified 101 incident cases of BCC.
283                                 In the first cohort, we assigned (in a 3:1 ratio) patients who had th
284 he Severe Asthma Research Program (SARP) III cohort, we determined the association between DHEA-sulfa
285                              Among the birth cohort, we measured biomarkers of gut inflammation (myel
286                            For a replication cohort, we meta-analyzed data from 36 cohorts with 1,051
287     By analysing two published breast cancer cohort, we signifies that MOVICS can serve a wide range
288 and clinical characteristics of this patient cohort were compared.
289 racteristic curve in the external validation cohorts were 83.5% (95% confidence interval [CI], 75.4-9
290                                        Three cohorts were defined as follows: 1) ICU survivors; 2) on
291  = 37, control = 45), and finally in a third cohort where the correlation with 18F-GTP1 tau PET was e
292 isease = 20, control = 20), then in a second cohort where the IWG-2 biomarker criteria were applied (
293                           Another 62-patient cohort who underwent CT pulmonary angiography before the
294 ant Inherited Alzheimer Network) study group cohort with amyloid positron emission tomography and beh
295 ompared to children from a high-risk allergy cohort with comparable rates of parental atopy.
296  a large unselected population-based patient cohort with full clinical follow-up (n = 928), we invest
297 l validation was performed in an independent cohort with primary chemotherapy from Heidelberg, German
298 cation cohort, we meta-analyzed data from 36 cohorts with 1,051,723 patients from OptumLabs Data Ware
299 s stratifying patients into more homogeneous cohorts with shared biological features, potentially fac
300 9 subjects with very asymmetric ectasia (VAE cohort) with and without their Rigid Gas Permeable conta
301 Guidelines for leisure time was noted in the cohort without NAFLD.

 
Page Top